About Ultromics
Founded in 2017 as a spin-out from the University of Oxford, Ultromics develops AI-powered software for echocardiogram analysis to aid cardiovascular disease diagnosis. Its flagship EchoGo® platform is a cloud-based SaaS system that uses machine learning to detect heart conditions such as heart failure (HFpEF) and cardiac amyloidosis from routine echocardiograms. The technology is FDA-cleared and Medicare-reimbursed, and is deployed in partnership with leading healthcare institutions including the NHS and Mayo Clinic.
Company details
Funding
Total raised
$116M
Last stage
Series C
Investors
Founders
Ross Upton
PhD, CEO and Co-Founder of Ultromics. Completed his PhD in Cardiovascular Medicine at the University of Oxford, where he co-developed the AI algorithm underpinning Ultromics' technology. Spun the company out of Oxford in 2017.
LinkedInPaul Leeson
Professor at the University of Oxford and co-inventor of the core AI algorithm. Co-founded Ultromics in 2017 alongside Ross Upton.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.